ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,308Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 1749

$1.95M Total Retail Price of All Prescriptions

Rank: 8 out of 1749

813 Patients Receiving at Least One Drug in Part D
26%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 813 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

2% of this provider’s 813 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

4% of this provider’s 2,691 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$136 was the average price of a prescription from this provider, compared to $143 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
OLANZAPINE 862 201 1 6
RISPERIDONE 703 126 2 1
QUETIAPINE FUMARATE 688 82 3 4
BENZTROPINE MESYLATE 652 25 R 4 3
DIVALPROEX SODIUM 628 136 5 15
ZOLPIDEM TARTRATE 598 71 6 9
TRAZODONE HCL 580 106 7 2
LAMOTRIGINE 543 134 8 14
LITHIUM CARBONATE 530 82 9 20
FLUOXETINE HCL 437 104 10 8
ABILIFY 364 14 11 5
TOPIRAMATE 328 29 12 29
HALOPERIDOL 319 54 13 21
SERTRALINE HCL 318 120 14 7
SEROQUEL 252 24 15 24
CYMBALTA 250 25 16 12
VENLAFAXINE HCL ER 240 51 17 17
BUPROPION XL 232 46 18 18
CITALOPRAM HBR 210 78 19 10
DIVALPROEX SODIUM ER 207 23 20 13
BUPROPION HCL SR 207 60 20 22
INVEGA SUSTENNA 202 0 22 32
PAROXETINE HCL 197 70 23 19
BUPROPION HCL 196 70 24 61
PERPHENAZINE 191 47 25 44
ZIPRASIDONE HCL 188 41 26 28
TRIHEXYPHENIDYL HCL 182 35 R 27 33
CLOZAPINE 175 0 28 11
SEROQUEL XR 156 13 29 25
CARBAMAZEPINE 152 21 30 46
ESCITALOPRAM OXALATE 149 34 31 23
GABAPENTIN 142 21 32 27
LEVOTHYROXINE SODIUM 138 36 33 37
HYDROXYZINE PAMOATE 136 0 R 34 43
ALPRAZOLAM 129 75 35 71
CHLORPROMAZINE HCL 124 0 36 48
THIOTHIXENE 124 28 36 74
MIRTAZAPINE 108 72 38 16
INVEGA 107 0 39 45
PROPRANOLOL HCL 102 0 40 41
LORAZEPAM 98 46 41 67
HALOPERIDOL DECANOATE 100 88 0 42 132
GEODON 81 15 43 55
AMITRIPTYLINE HCL 76 60 R 44 47
LEXAPRO 76 26 44 38
VENLAFAXINE HCL 75 58 46 80
BUSPIRONE HCL 73 21 47 26
VIIBRYD 73 0 47 66
LATUDA 70 0 49 35
NORTRIPTYLINE HCL 70 0 49 73
OXCARBAZEPINE 68 0 51 39
METHYLPHENIDATE HCL 65 13 52 84
TRIFLUOPERAZINE HCL 63 0 53 87
AMPHETAMINE SALT COMBO 56 11 S2 54 53
DOXEPIN HCL 56 0 54 64
PRISTIQ ER 55 0 56 49
DONEPEZIL HCL 53 48 57 30
FLUPHENAZINE HCL 53 0 57 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.